August 2015 Co-Medical Directors Mark Berman, MD, FACS & Elliot Lander, MD, FACS have just released their first book, The Stem Cell Revolution. The book describes their journey into the growing arena of clinical stem cell therapy, by highlighting not only the road that brought a team of physicians together, but also real stories from…Details
St. James Hospital Chairman Josie Muscat, MD, ARDMS performed his first stem cell procedures in Zabbar, Malta at the end of May 2015 after training at the Cell Surgical Network in Rancho Mirage, California. CSN Headquarters’ Surgical Technologist Shawntae Dowell was present to teach his team the process. To learn more about Dr. Muscat, click…Details
Aspire Ability is a non-profit close to our hearts, a leader in disability awareness and lifestyle adaptations, providing services to people with physical disabilities. You can check out their booth at the Whitewood Campground Event in South Dakota from 06/29/15 – 08/08/15, as well as founder Jessica Day’s stem cell documentary at www.aspireability.com. Jessica Day,…Details
CSN welcomes Erica Song, MD, FACOG from Englewood, New Jersey and orthopedic surgeon Marc A. Roux, MD, FAAOS from Waxahachie, Texas. Erica Song, MD, FACOG Founder, New Jersey Stem Cell Treatment Center, a division of Vibrant Life Medicine Englewood, New Jersey 201.569.6190 firstname.lastname@example.org http://www.vibrantlifemedicine.com Marc A. Roux, MD, FAAOS Waxahachie Orthopedics and Sports Medicine (WOSM)…Details
JUNE 5-6 2015 Dr. Berman accepted a position on the Advisory Committee for the Academy of Regenerative Practices (ARP), and presented the following lecture at their first annual conference in Fort Lauderdale, Florida. Mark Berman, MD, FACS presents: “Controlled Studies” A discussion of in-clinic cellular treatments and current empirical findings. Results are largely positive, and dependent upon…Details
Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study involved 21 people whose disability due to MS had…Details
Evidence-based medicine and intuition both work By Devorah E. Klein, Gary Klein, and Shawna J. Perry | June 11, 2014, Wednesday | Print Edition EVERY health-care system balances coverage, quality and cost — often focusing on one or two at the expense of the others. It is clear that the US has room for improvement…Details